Newsletter | December 3, 2024

Best of November: Top 5 Insights In Drug Formulation & Delivery

Drug Delivery Leader

TOP 5 INSIGHTS IN DRUG FORMULATION AND DELIVERY 

NOVEMBER EDITION

#1 - Understanding Essential Drug Delivery Outputs: Things To Know About EDDOs

Fran DeGrazio summarizes and comments on key clarifications and recommendations that emerged in a Drug Delivery Live! online event on the FDA's draft guidance on Essential Drug Delivery Outputs (EDDOs), which she moderated.

#2 - Needle-Free Rescue Therapies With Crossject's Patrick Alexandre And Dan Chiche

The CEO and CMO of emergency medicine company Crossject discuss how advances in needle-free autoinjectors can enable nearly immediate emergency treatment of an epileptic seizure or other sudden attack.

#3 - Bacterial Endotoxin Testing, Part 4: Key Tests For Endotoxin Detection

This article concludes the author's series on bacterial endotoxin testing. It discusses best practices for the labeled lysate sensitivity test, non-interfering dilution determination, and more.

#4 - Gene Therapy Delivery With Battelle's Gabe Meister And Tony Duong

In this episode of Supplier Horizons, Gabe Meister and Tony Duong from biopharmaceutical research and development company Battelle discuss the promise of polymer nanoparticles as delivery vehicles for treating rare diseases with in vivo gene therapies.

#5 - 5 Areas Of Drug Delivery Innovation To Watch In 2025

2024 has seen some promising advances in drug delivery technology. Strategic pharma/biotech companies may wish to seize these opportunities for their drug candidates in 2025.